High-dose thiotepa, in conjunction with melphalan, followed by autologous hematopoietic stem cell transplantation in patients with pediatric solid tumors, including brain tumors - Poll - MDSpire

High-dose thiotepa, in conjunction with melphalan, followed by autologous hematopoietic stem cell transplantation in patients with pediatric solid tumors, including brain tumors

  • By

  • Junichi Hara

  • Kimikazu Matsumoto

  • Naoko Maeda

  • Mariko Takahara-Matsubara

  • Saori Sugimoto

  • Hiroaki Goto

  • November 3, 2022

  • 0 min

Share

Original Source(s)

High-dose thiotepa, in conjunction with melphalan, followed by autologous hematopoietic stem cell transplantation in patients with pediatric solid tumors, including brain tumors

  • by Junichi Hara, Kimikazu Matsumoto, Naoko Maeda, Mariko Takahara-Matsubara, Saori Sugimoto, Hiroaki Goto

  • November 3, 2022

Related Content

Influence of postoperative D-dimer evaluation and intraoperative use of intermittent pneumatic vein compression (IPC) on detection and development of perioperative venous thromboembolism in brain tumor surgery

Technical challenges and outcomes of stereotactic biopsies in the posterior fossa: Experience with ZD-inomed and leksell vantage frames

Hyperprogression of brain metastases following initiation of immune checkpoint inhibitors